Reprogramming Cancer into Antigen-Presenting Cells as a Novel Immunotherapy

Miles H Linde,Amy C Fan,Thomas Köhnke,Aaron C Trotman-Grant,Sarah F Gurev,Paul Phan,Feifei Zhao,Naomi L Haddock,Kevin A Nuno,Eric J Gars,Melissa Stafford,Payton L Marshall,Christopher G Dove,Ian L Linde,Niklas Landberg,Lindsay P Miller,Robbie G Majzner,Tian Yi Zhang,Ravindra Majeti
DOI: https://doi.org/10.1158/2159-8290.CD-21-0502
2023-05-04
Abstract:Therapeutic cancer vaccination seeks to elicit activation of tumor-reactive T cells capable of recognizing tumor-associated antigens (TAA) and eradicating malignant cells. Here, we present a cancer vaccination approach utilizing myeloid-lineage reprogramming to directly convert cancer cells into tumor-reprogrammed antigen-presenting cells (TR-APC). Using syngeneic murine leukemia models, we demonstrate that TR-APCs acquire both myeloid phenotype and function, process and present endogenous TAAs, and potently stimulate TAA-specific CD4+ and CD8+ T cells. In vivo TR-APC induction elicits clonal expansion of cancer-specific T cells, establishes cancer-specific immune memory, and ultimately promotes leukemia eradication. We further show that both hematologic cancers and solid tumors, including sarcomas and carcinomas, are amenable to myeloid-lineage reprogramming into TR-APCs. Finally, we demonstrate the clinical applicability of this approach by generating TR-APCs from primary clinical specimens and stimulating autologous patient-derived T cells. Thus, TR-APCs represent a cancer vaccination therapeutic strategy with broad implications for clinical immuno-oncology. Significance: Despite recent advances, the clinical benefit provided by cancer vaccination remains limited. We present a cancer vaccination approach leveraging myeloid-lineage reprogramming of cancer cells into APCs, which subsequently activate anticancer immunity through presentation of self-derived cancer antigens. Both hematologic and solid malignancies derive significant therapeutic benefit from reprogramming-based immunotherapy. This article is highlighted in the In This Issue feature, p. 1027.
What problem does this paper attempt to address?